Related Experiment Video
Updated: Jan 17, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Investigating Causal Links between Metabolite Profiles and Ulcerative Colitis: A Bidirectional Mendelian
Parvin Zarei1, Zoha Kamali1,2, Ammar Hassanzadeh Keshteli3
1Department of Bioinformatics, Isfahan University of Medical Sciences, Isfahan, Iran.
Total lipids in small high-density lipoprotein levels show a potential link to ulcerative colitis (UC) development. Further research may identify these lipids as biomarkers for UC screening and prevention.
Area of Science:
- Genetics
- Metabolomics
- Gastroenterology
Background:
- Ulcerative colitis (UC) development is influenced by metabolic biomarkers, but causal links remain unclear.
- Investigating the relationship between blood metabolites and UC is crucial for understanding disease mechanisms.
Purpose of the Study:
- To evaluate the causal relationships between 503 blood metabolites and ulcerative colitis (UC) using a bidirectional Mendelian randomization study.
- To identify potential metabolic biomarkers for UC screening, prevention, and therapeutic target discovery.
Main Methods:
- Utilized genome-wide association study (GWAS) data for 503 blood metabolites and UC from European ancestry cohorts.
- Employed inverse variance weighted (IVW) method for primary analysis and various sensitivity analyses (MR-Egger, weighted median) to ensure robustness.
Main Results:
- A marginal significant positive association was observed between total lipids in small high-density lipoprotein levels (S.HDL.L) and UC development (OR = 1.167, P = 0.051).
- No statistically significant causal effect of UC on the studied metabolites was detected.
Conclusions:
- Total lipids in S.HDL.L may serve as a potential circulating biomarker for UC screening and prevention.
- These lipids could be candidate molecules for elucidating UC pathogenesis and identifying drug targets.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD